Neil Chatterji
Stock Analyst at B. Riley Securities
(0.64)
# 3,591
Out of 4,667 analysts
16
Total ratings
25%
Success rate
-10.86%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $41.81 | +19.59% | 2 | Nov 9, 2023 | |
ARAY Accuray | Reiterates: Buy | $7.5 | $1.83 | +309.84% | 1 | Oct 4, 2023 | |
ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $21.47 | -16.16% | 2 | Sep 8, 2023 | |
KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.65 | +23.29% | 1 | Sep 7, 2023 | |
OPRX OptimizeRx | Maintains: Buy | $28 → $18 | $4.42 | +307.24% | 2 | Aug 15, 2023 | |
HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.90 | +288.89% | 3 | Aug 15, 2023 | |
STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.03 | +170.94% | 2 | Mar 6, 2023 | |
CLPT ClearPoint Neuro | Reinstates: Buy | $14 | $10.96 | +27.74% | 1 | Feb 16, 2023 | |
FNA Paragon 28 | Initiates: Buy | $32 | $10.35 | +209.18% | 1 | Dec 14, 2022 | |
BFLY Butterfly Network | Initiates: Buy | $9.5 | $3.32 | +186.14% | 1 | Oct 4, 2022 |
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $41.81
Upside: +19.59%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.83
Upside: +309.84%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $21.47
Upside: -16.16%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.65
Upside: +23.29%
OptimizeRx
Aug 15, 2023
Maintains: Buy
Price Target: $28 → $18
Current: $4.42
Upside: +307.24%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.90
Upside: +288.89%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.03
Upside: +170.94%
ClearPoint Neuro
Feb 16, 2023
Reinstates: Buy
Price Target: $14
Current: $10.96
Upside: +27.74%
Paragon 28
Dec 14, 2022
Initiates: Buy
Price Target: $32
Current: $10.35
Upside: +209.18%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $3.32
Upside: +186.14%